Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial

Journal

Related Articles

See more

Details

  • CRID
    1370850167421828353
  • Data Source
    • Crossref
Back to top